Foresight Global Investors, Inc. Novartis Ag Transaction History
Foresight Global Investors, Inc.
- $203 Billion
- Q1 2024
A detailed history of Foresight Global Investors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Foresight Global Investors, Inc. holds 197,375 shares of NVS stock, worth $21.3 Million. This represents 9.4% of its overall portfolio holdings.
Number of Shares
197,375
Previous 131,975
49.55%
Holding current value
$21.3 Million
Previous $13.3 Billion
43.27%
% of portfolio
9.4%
Previous 7.64%
Shares
3 transactions
Others Institutions Holding NVS
# of Institutions
1,350Shares Held
140MCall Options Held
1.15MPut Options Held
866K-
Primecap Management CO Pasadena, CA12.4MShares$1.34 Billion0.91% of portfolio
-
Dodge & Cox San Francisco, CA12.4MShares$1.34 Billion0.73% of portfolio
-
Morgan Stanley New York, NY7.26MShares$785 Million0.06% of portfolio
-
Dimensional Fund Advisors LP Austin, TX6.02MShares$651 Million0.16% of portfolio
-
Loomis Sayles & CO L P5.92MShares$640 Million0.81% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $233B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...